American College of Rheumatology (ACR) 2010 SLE Highlights: The Frost & Sullivan Perspective

 


This research segment presents the key highlights from the 2010 American College of Rheumatology (ACR) for the treatment of systemic lupus erythematosus (SLE). The purpose of this study is to highlight the current and future treatments for SLE, identify and analyze key data presented at ACR 2010, and discuss recent developments in the SLE market. This study includes content from interviews conducted with key opinion leaders (KOLs) and company executives.

Regular Price: USD 1,500

Special Price USD 1,050

30% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,050

PAY BY INVOICE

Be the first to review this product

Table of Contents

American College of Rheumatology (ACR) 2010 SLE Highlights: The Frost & Sullivan PerspectiveAmerican College of Rheumatology (ACR) 2010 SLE Highlights: The Frost & Sullivan PerspectiveAmerican College of Rheumatology (ACR) 2010 SLE Highlights: The Frost & Sullivan Perspective




Related Research

Release Date : 11-Aug-17

Region : North America

Release Date : 10-Aug-17

Region : North America

Release Date : 09-Aug-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.